A method for treating a disease and drug units for use in performing such method. The method involves invading and flooding select cells of a living being with a drug or medical material to correct a genetic flaw, destroy or otherwise prevent the production or multiplication of a disease defining substance such as a virus in such cells or prevent the cells from uncontrollably growing or dividing. The method involves injecting or otherwise administering a dose of drug units to the body or bloodst...

A pharmaceutical composition for use in the treatment of chronic Graft-versus-host diseases as well as autoimmune diseases, in particular for the treatment of systemic lupus erythematosus containing as an active ingredient at least one compound of the formulae 1 or 2 ##STR1## the latter being present per se or in the form of a physiologically tolerable salt. The invention also relates to a dosage unit form of said pharmaceutical composition and a method of treating chronic Graft-versus host dise...

Beraprost, a agent for treating hepatic diseases, that is safe and chemically stable is disclosed.

A method of inhibiting autoimmune diseases comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.

A method and apparatus for alleviating or curing human ailments, afflictions and diseases by application of magnetism. A north pole surface of a magnet is applied to the hands or at least one hand of a person being treated, and is maintained in contact for a time period or periods in accordance with the ailments or afflictions being treated. The magnet is maintained in contact for a time period or periods sufficient to elicit affirmative response, alleviation, or cure. Concurrently with applicat...

A remedy for inflammatory intestinal diseases which contains as the active ingredient 9-(4-acetyl-3-hydroxy-2-n-propylphenoxymethyl)-3-(1H-tetrazol-5-yl)-4H-pyr ido[1,2-a]pyrimidine-4-one represented by the formula: ##STR1## or a physiologically acceptable salt thereof. The compound specified in the present invention can remedy not only inflammatory responses caused in inflammatory intestinal diseases in a short time but also remove the symptoms deriving from digestive organs, which are caused t...

A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.

A process for preparing a dermatological lotion comprises sequentially adding 160 to 240 g. salicylic acid, 160 to 240 g. alum powder and 45 to 55 tincture of iodine to 800 to 1200 ml. ethyl alcohol to provide a mixture, homogenizing the mixture, and then maintaining the homogenized mixture quiescent for at least one week.

A therapeutic agent for treating a hematopoietic disease containing, as an active ingredient, a glycoprotein which is recovered from human urine and acts upon the human bone marrow cells to stimulate the differentiation and proliferation of granulocytes-monocytes lineages thereof, or an active peptide fragment thereof or a derivative of said fragment, said therapeutic agent being administered after transplantation of the bone marrow.

A method for treating a lung disease causing an abnormal decrease in blood oxygen level comprising administering at least one l-carnitine derivative having the formula ##EQU1## wherein R is hydrogen or a fatty acid residue having 4 to 24 carbon atoms.